Mechanism and Antiviral Therapy in Preventing Mother-to-Child Transmission During Pregnancy with Hepatitis B Virus Infection

被引:1
|
作者
Zhao, Mengyu [1 ,2 ]
Zou, Huaibin [1 ,2 ]
Chen, Yu [1 ,2 ]
Duan, Zhongping [1 ]
机构
[1] Capital Med Univ, Beijing Youan Hosp, Difficult & Complicated Liver Dis & Artificial Li, Beijing, Peoples R China
[2] Beijing Municipal Key Lab Liver Failure & Artific, Beijing, Peoples R China
关键词
Antiviral Therapy; Hepatitis B Virus (HBV); Mother-to-Child Transmission (MTCT); Pregnancy; TENOFOVIR DISOPROXIL FUMARATE; CLINICAL-PRACTICE GUIDELINES; INFANT TRANSMISSION; SURFACE-ANTIGEN; INTRAUTERINE INFECTION; PERINATAL TRANSMISSION; VERTICAL TRANSMISSION; TELBIVUDINE TREATMENT; VACCINATION PROGRAM; HBV TRANSMISSION;
D O I
10.5812/hepatmon.81903
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Context: Mother-to-child transmission (MTCT) is one of the main transmission routes of chronic hepatitis B virus (HBV) infection. The successful rate of preventing MTCT has increased to over 90% after the administration of passive-active immunoprophylaxis (vaccine and hepatitis B immunoglobulin (HBIG)) on infants born to hepatitis B surface antigen (HBsAg)-positive mothers. However, 5%-10% of the infants had chronic HBV infection who were born to mothers with high HBV DNA levels. Therefore, the current domestic and international guidelines recommended that antiviral therapy in late pregnancy was to further decrease the MTCT rate. This study aimed at reviewing the mechanisms of MTCT and controversial issues in antiviral therapy for pregnant women with high viral load in order to provide clinicians with some strategies for preventing MTCT of HBV. Evidence Acquisition: Relevant English published papers were searched using online databases, including PubMed and EMBASE from January 2000 to January 2019. We summarized the findings of 61 relevant studies in this review. Results: The mechanism of MTCT is still unclear and further studies are needed. Antiviral therapy for pregnant women with high viral load can reduce the rate of MTCT and provide the appropriate safety for mothers and infants. Conclusions: The mechanisms underlying MTCT of HBV is still unknown and more investigations are required. The efficacy and safety of taking tenofovir disoproxil fumarate (TDF) orally in pregnant women with high viral load in the second or third trimester of pregnancy to block MTCT of HBV have been proved. The withdrawal of antiviral therapy during pregnancy due to MTCT should not exceed 3 months after delivery at the latest. Most pregnant women tend to suffer from increased alanine aminotransferase (ALT) after discontinuing antiviral drugs during pregnancy. Accordingly, close ALT levels monitoring after drug discontinuation is essential.
引用
收藏
页数:7
相关论文
共 50 条
  • [11] Mother-to-child transmission of hepatitis E virus infection
    Sarman Singh
    Alok Mohanty
    Y. K. Joshi
    Deepika Deka
    Sujit Mohanty
    S. K. Panda
    [J]. The Indian Journal of Pediatrics, 2003, 70 (1) : 37 - 39
  • [12] Efficacy of antiviral therapy during the second or the third trimester for preventing mother-to-child hepatitis B virus transmission: a systematic review and meta-analysis
    Yang, Xiuhan
    Zhong, Xiaozhu
    Liao, Huihua
    Lai, Yongchang
    [J]. REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2020, 62
  • [13] Adverse pregnancy outcomes and mother-to-child transmission in patients with hepatitis B virus infection and intrahepatic cholestasis of pregnancy
    Zhang, Chong
    Wei, Hong
    Zhu, Yun-Xia
    [J]. GINEKOLOGIA POLSKA, 2022, 93 (05) : 396 - 404
  • [14] Efficacy of antepartum administration of hepatitis B immunoglobulin in preventing mother-to-child transmission of hepatitis B virus
    Zhao, Mengyu
    Zou, Huaibin
    Chen, Yu
    Zheng, Sujun
    Duan, Zhongping
    [J]. JOURNAL OF VIRAL HEPATITIS, 2019, 26 (09) : 1059 - 1065
  • [15] Mother-to-child transmission of hepatitis B virus in Ethiopia
    Johannessen, A.
    Stene-Johansen, K.
    Mekasha, B.
    Berhe, N.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S470 - S470
  • [16] Efficacy of antiviral therapy for the prevention of mother-to-child transmission of hepatitis B virus and the risk of postpartum hepatitis flare after discontinuation of antiviral therapy
    Kawamura, Hayato
    Matsuura, Kentaro
    Ito, Koichi
    Sugiura, Tokio
    Suzuki, Takanori
    Fujiwara, Kei
    Kataoka, Hiromi
    Tanaka, Yasuhito
    [J]. HEPATOLOGY RESEARCH, 2024,
  • [17] Mother-to-Child Transmission of Hepatitis B Virus in Ethiopia
    Johannessen, Asgeir
    Mekasha, Bitsatab
    Desalegn, Hailemichael
    Aberra, Hanna
    Stene-Johansen, Kathrine
    Berhe, Nega
    [J]. VACCINES, 2021, 9 (05)
  • [18] Prevention of the mother-to-child transmission of Hepatitis B virus
    Pol, Stanislas
    Jourdain, Gonzague
    [J]. LIVER INTERNATIONAL, 2018, 38 (07) : 1177 - 1178
  • [19] Considerations of antiviral treatment to interrupt mother-to-child transmission of hepatitis B virus in China
    Cui, Fuqiang
    Woodring, Joseph
    Chan, Polin
    Xu, Fujie
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2018, 47 (05) : 1529 - 1537
  • [20] Prevention strategies of mother-to-child transmission of hepatitis B virus (HBV) infection
    Hu, Yao
    Yu, Hui
    [J]. PEDIATRIC INVESTIGATION, 2020, 4 (02) : 133 - 137